Total Valuation
BioQuest has a market cap or net worth of $1.97M. The enterprise value is $1.14M.
Market Cap$1.97M
Enterprise Value$1.14M
Share Statistics
BioQuest has 29,895,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,895,230
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioQuest’s return on equity (ROE) is 0.82 and return on invested capital (ROIC) is 135.23%.
Return on Equity (ROE)0.82
Return on Assets (ROA)-547.85
Return on Invested Capital (ROIC)135.23%
Return on Capital Employed (ROCE)0.84
Revenue Per Employee44.64K
Profits Per Employee-226.26K
Employee Count4
Asset Turnover108.09
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioQuest is ―. BioQuest’s PEG ratio is 0.04.
PE Ratio―
PS Ratio11.05
PB Ratio-1.79
Price to Fair Value-1.79
Price to FCF-6.57
Price to Operating Cash Flow-1.89
PEG Ratio0.04
Income Statement
In the last 12 months, BioQuest had revenue of 178.56K and earned -905.05K in profits. Earnings per share was -0.03.
Revenue178.56K
Gross Profit69.04K
Operating Income-838.05K
Pretax Income-905.05K
Net Income-905.05K
EBITDA-838.05K
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -299.10K and capital expenditures 3.00, giving a free cash flow of -299.09K billion.
Operating Cash Flow-299.10K
Free Cash Flow-299.09K
Free Cash Flow per Share-0.01
Dividends & Yields
BioQuest pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta33.15
52-Week Price Change-93.39%
50-Day Moving Average0.07
200-Day Moving Average0.40
Relative Strength Index (RSI)<0.01
Average Volume (3m)163.00
Important Dates
BioQuest upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
BioQuest as a current ratio of <0.01, with Debt / Equity ratio of -34.77%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.19
Net Debt to EBITDA-0.46
Interest Coverage Ratio-12.51
Taxes
In the past 12 months, BioQuest has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioQuest EV to EBITDA ratio is -2.81, with an EV/FCF ratio of -7.84.
EV to Sales13.19
EV to EBITDA-2.81
EV to Free Cash Flow-7.84
EV to Operating Cash Flow-7.84
Balance Sheet
BioQuest has $1.65K in cash and marketable securities with $383.60K in debt, giving a net cash position of -$381.94K billion.
Cash & Marketable Securities$1.65K
Total Debt$383.60K
Net Cash-$381.94K
Net Cash Per Share-$0.01
Tangible Book Value Per Share-$0.03
Margins
Gross margin is -167.72%, with operating margin of -469.33%, and net profit margin of -506.85%.
Gross Margin-167.72%
Operating Margin-469.33%
Pretax Margin-506.85%
Net Profit Margin-506.85%
EBITDA Margin-469.33%
EBIT Margin-469.33%
Analyst Forecast
The average price target for BioQuest is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast23.68%
EPS Growth Forecast11.66%